JOSE LUIS
LOBO BERISTAIN
Investigador/a en el periodo 2006-2022
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadoras/es de Harvard Medical School (9)
2023
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981
-
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings
Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 1, pp. 34-46
2022
-
Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial
Thrombosis Journal, Vol. 20, Núm. 1
-
Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model
Frontiers in Cardiovascular Medicine, Vol. 9
-
Major bleeding in patients with pulmonary embolism presenting with syncope
European journal of clinical investigation, Vol. 52, Núm. 7, pp. e13774
-
Statin use and 30-day mortality in patients with acute symptomatic pulmonary embolism
Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 8, pp. 1839-1851
2021
-
Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989
-
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism
European Respiratory Journal, Vol. 58, Núm. 1
-
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial
JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285